Related references
Note: Only part of the references are listed.Inflammation and the pathogenesis of diabetic nephropathy
Jun Wada et al.
CLINICAL SCIENCE (2013)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets
Akira Mima
JOURNAL OF DIABETES RESEARCH (2013)
Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes
D. K. Kim et al.
DIABETOLOGIA (2012)
Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: Involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-kappa B
Qi Sun et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Diabetic Nephropathy and Extracellular Matrix
S. O. Kolset et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Inflammation in Diabetic Nephropathy
Andy K. H. Lim et al.
MEDIATORS OF INFLAMMATION (2012)
Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression
Mao Zheng et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2009)
Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation
S. S. Ghosh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Possible Mechanism of the Anti-inflammatory Activity of Ruscogenin: Role of Intercellular Adhesion Molecule-1 and Nuclear Factor-κB
Ya-Lin Huang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice
Mei-chin Yin et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Antithrombotic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents
Junping Kou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Macrophage accumulation in human progressive diabetic nephropathy
Duy Nguyen et al.
NEPHROLOGY (2006)
Anti-inflammatory activities of aqueous extract from Radix ophiopogon japonicus and its two constituents
JP Kou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
FY Chow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
NF-κB activation and overexpression of regulated genes in human diabetic nephropathy
S Mezzano et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy
ML Gross et al.
DIABETOLOGIA (2003)
HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats
H Usui et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy
T Morii et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Emerging roles of PPARs in inflammation and immunity
RA Daynes et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Transcription factor-κB (NF-κB) and renal disease
C Guijarro et al.
KIDNEY INTERNATIONAL (2001)
Share Paper
